Home / Top News / SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Arcimoto Inc. of Class Action Lawsuit and Upcoming Deadline – FUV
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Arcimoto Inc. of Class Action Lawsuit and Upcoming Deadline – FUV
NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Arcimoto Inc. (“Arcimoto” or the “Company”) (NASDAQ: FUV) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-02870, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired the publicly traded securities of Arcimoto between February 14, 2018 and March 22, 2021, both dates inclusive (the “Class Period”). Plaintiff seeks to recover compensable damages cau
Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Amdocs Limited ( Amdocs or the Company ) (NASDAQ: DOX), and certain of its officers. The class action, filed in the United States District Court for the Central District of California, and docketed under 21-cv-03078, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Amdocs ordinary shares between December 13, 2016 and March 30, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Message :
Required fields
NEW YORK, May 25, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ( FibroGen or the Company ) (NASDAQ: FGEN) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-03212, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired FibroGen securities and/or sold put options from November 8, 2019, through and including April 6, 2021 (the Class Period ), seeking to recover damages pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ), 15 U.S.C. §§ 78j(b) and 78t(a), and Rule 10b-5 promulgated thereunder (the Class ).
Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ( FibroGen or the Company ) (NASDAQ: FGEN) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-03212, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired FibroGen securities and/or sold put options from November 8, 2019, through and including April 6, 2021 (the Class Period ), seeking to recover damages pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ), 15 U.S.C. §§ 78j(b) and 78t(a), and Rule 10b-5 promulgated thereunder (the Class ).
Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Romeo Power, Inc. ( Romeo or the Company ) (f/k/a RMG Acquisition Corp.) (NYSE: RMO) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-04058, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of Romeo between October 5, 2020 through March 30, 2021, inclusive (the Class Period ). Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the Exchange Act ).